304 related articles for article (PubMed ID: 25798599)
1. Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein.
Bradley DT; Bourke TW; Fairley DJ; Borrow R; Shields MD; Zipfel PF; Hughes AE
PLoS One; 2015; 10(3):e0120757. PubMed ID: 25798599
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association studies reveal the role of polymorphisms affecting factor H binding protein expression in host invasion by Neisseria meningitidis.
Earle SG; Lobanovska M; Lavender H; Tang C; Exley RM; Ramos-Sevillano E; Browning DF; Kostiou V; Harrison OB; Bratcher HB; Varani G; Tang CM; Wilson DJ; Maiden MCJ
PLoS Pathog; 2021 Oct; 17(10):e1009992. PubMed ID: 34662348
[TBL] [Abstract][Full Text] [Related]
3. Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines.
Yee WX; Barnes G; Lavender H; Tang CM
Trends Microbiol; 2023 Aug; 31(8):805-815. PubMed ID: 36941192
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.
Davila S; Wright VJ; Khor CC; Sim KS; Binder A; Breunis WB; Inwald D; Nadel S; Betts H; Carrol ED; de Groot R; Hermans PW; Hazelzet J; Emonts M; Lim CC; Kuijpers TW; Martinon-Torres F; Salas A; Zenz W; Levin M; Hibberd ML;
Nat Genet; 2010 Sep; 42(9):772-6. PubMed ID: 20694013
[TBL] [Abstract][Full Text] [Related]
5. FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
Lo Presti A; Carannante A; Fazio C; Neri A; Vacca P; Ambrosio L; Lista F; Fillo S; Stefanelli P
PLoS One; 2023; 18(2):e0277976. PubMed ID: 36795654
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis.
Piet JR; Brouwer MC; Exley R; van der Veen S; van de Beek D; van der Ende A
PLoS One; 2012; 7(10):e47973. PubMed ID: 23110143
[TBL] [Abstract][Full Text] [Related]
7. Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.
Tzeng YL; Giuntini S; Berman Z; Sannigrahi S; Granoff DM; Stephens DS
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958529
[TBL] [Abstract][Full Text] [Related]
8. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.
Hoiseth SK; Murphy E; Andrew L; Vogel U; Frosch M; Hellenbrand W; Abad R; Vazquez JA; Borrow R; Findlow J; Taha MK; Deghmane AE; Caugant DA; Kriz P; Musilek M; Mayer LW; Wang X; Macneil JR; York L; Tan CY; Jansen KU; Anderson AS
Pediatr Infect Dis J; 2013 Oct; 32(10):1096-101. PubMed ID: 23694830
[TBL] [Abstract][Full Text] [Related]
9. Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.
Bianchi F; Veggi D; Santini L; Buricchi F; Bartolini E; Lo Surdo P; Martinelli M; Finco O; Masignani V; Bottomley MJ; Maione D; Cozzi R
FASEB J; 2019 Nov; 33(11):12099-12111. PubMed ID: 31442074
[TBL] [Abstract][Full Text] [Related]
10. fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.
Giuntini S; Vu DM; Granoff DM
Vaccine; 2013 Aug; 31(38):4192-9. PubMed ID: 23791680
[TBL] [Abstract][Full Text] [Related]
11. Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.
Spinsanti M; Brignoli T; Bodini M; Fontana LE; De Chiara M; Biolchi A; Muzzi A; Scarlato V; Delany I
PLoS Pathog; 2021 Mar; 17(3):e1009461. PubMed ID: 33770146
[TBL] [Abstract][Full Text] [Related]
12. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa.
Ganesh K; Allam M; Wolter N; Bratcher HB; Harrison OB; Lucidarme J; Borrow R; de Gouveia L; Meiring S; Birkhead M; Maiden MC; von Gottberg A; du Plessis M
BMC Microbiol; 2017 Feb; 17(1):40. PubMed ID: 28222677
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp).
Abad R; García-Amil C; Navarro C; Martín E; Martín-Díaz A; Vázquez JA
J Infect; 2021 Apr; 82(4):37-44. PubMed ID: 33610688
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease.
Harris SL; Zhu D; Murphy E; McNeil LK; Wang X; Mayer LW; Harrison LH; Jansen KU; Anderson AS
Hum Vaccin; 2011; 7 Suppl(Suppl):68-74. PubMed ID: 21245657
[TBL] [Abstract][Full Text] [Related]
16. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
[TBL] [Abstract][Full Text] [Related]
17. Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.
Marsh JW; Shutt KA; Pajon R; Tulenko MM; Liu S; Hollick RA; Kiehlbauch JA; Clark TA; Stephens DS; Arnold KE; Myers RA; Mayer LW; Harrison LH
Vaccine; 2011 Aug; 29(35):6049-58. PubMed ID: 21704667
[TBL] [Abstract][Full Text] [Related]
18. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).
Tzanakaki G; Xirogianni A; Tsitsika A; Clark SA; Kesanopoulos K; Bratcher HB; Papandreou A; Rodrigues CMC; Maiden MCJ; Borrow R; Tsolia M
Vaccine; 2021 Mar; 39(11):1621-1630. PubMed ID: 33597116
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of Host Genetic Determinants in the CFH Region and Susceptibility to Meningococcal Disease in a Central European Study Sample.
Biebl A; Muendlein A; Kinz E; Drexel H; Kabesch M; Zenz W; Elling R; Müller C; Keil T; Lau S; Simma B
Pediatr Infect Dis J; 2015 Oct; 34(10):1115-7. PubMed ID: 26135246
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
